Author | Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center | OncLive

Author | Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center

Articles

Dr. Daud on Dabrafenib/Trametinib Vs Immunotherapy in Melanoma

December 05, 2019

Video

Adil Daud, MD, discusses the combination of dabrafenib and trametinib versus immunotherapy in patients with BRAF V600-mutant metastatic melanoma.

Dr. Daud on Interferon Gamma as a Biomarker in Melanoma

November 08, 2019

Video

Adil Daud, MD, clinical professor, Department of Medicine (Hematology/Oncology) and director, Melanoma Clinical Research, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses research evaluating interferon gamma as a potential biomarker of response in melanoma.

Dr. Daud Discusses the Immunogenicity of Melanoma

May 17, 2019

Video

Adil Daud, MD, clinical professor, Department of Medicine, director, Melanoma Clinical Research, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses the immunogenicity of melanoma.

x